The emerging genetic landscape underlying cardiac conduction system function

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 91, Issue 6, 2011, Pages 578-585

  Arnolds, David E ^a   Chu, Alison ^a   Mcnally, Elizabeth M ^a   Nobrega, Marcelo A ^a   Moskowitz, Ivan P ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cardiac; Conduction; Development; GWAS; Heart; T box; Transcription factor

Indexed keywords

CD34 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DICKKOPF 1 PROTEIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; ION CHANNEL; POTASSIUM CHANNEL KCNQ1; PROTEIN P53; SODIUM CHANNEL NAV1.5; SODIUM CHANNEL NAV1.8; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR SOX5; TRANSCRIPTION FACTOR TBX3; TRANSCRIPTION FACTOR TBX5; UNCLASSIFIED DRUG; WNT11 PROTEIN; WNT7A PROTEIN;

ATRIOVENTRICULAR BLOCK; BODY MASS; CANCER INHIBITION; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CONGENITAL HEART MALFORMATION; DIASTOLIC BLOOD PRESSURE; DNA DAMAGE; ELECTROCARDIOGRAM; ELECTRONIC MEDICAL RECORD; GENE CONTROL; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEART BUNDLE BRANCH BLOCK; HEART DEATH; HEART DEVELOPMENT; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CONDUCTION SYSTEM; HEART MUSCLE CONTRACTILITY; HEART RATE; HOLT ORAM SYNDROME; HUMAN; NONHUMAN; PHENOTYPE; PR INTERVAL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; QRS COMPLEX; QT INTERVAL; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO;

ANIMALS; ELECTROCARDIOGRAPHY; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOME-WIDE ASSOCIATION STUDY; HEART CONDUCTION SYSTEM; HEART DISEASES; HUMANS;

METAZOA;

EID: 79958147805     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20800     Document Type: Review

References (87)

1. Arking DE, Khera A, Xing C, et al. 2009. Multiple independent genetic factors at NOS1AP modulate the QT interval in a multi-ethnic population. PLoS One 4: e4333.
2. Arking DE, Pfeufer A, Post W, et al. 2006. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet 38: 644-651.
3. Bakker ML, Boukens BJ, Mommersteeg MT, et al. 2008. Transcription factor Tbx3 is required for the specification of the atrioventricular conduction system. Circ Res 102: 1340-1349.
4. Bamshad M, Lin RC, Law DJ, et al. 1997. Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome. Nat Genet 16: 311-315.
5. Barwe SP, Jordan MC, Skay A, et al. 2009. Dysfunction of ouabain-induced cardiac contractility in mice with heart-specific ablation of na, K-ATPase beta1-subunit. J Mol Cell Cardiol 47: 552-60.
6. Basson CT, Bachinsky DR, Lin RC, et al. 1997. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 15: 30-35.
7. Basson CT, Cowley GS, Solomon SD, et al. 1994. The clinical and genetic spectrum of the Holt-Oram syndrome (heart-hand syndrome). N Engl J Med 330: 885-891.
8. Benjamin EJ, Rice KM, Arking DE, et al. 2009. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet 41: 879-881.
9. Bond J, Sedmera D, Jourdan J, et al. 2003. Wnt11 and Wnt7a are up-regulated in association with differentiation of cardiac conduction cells in vitro and in vivo. Dev Dyn 227: 536-543.
10. Briggs LE, Takeda M, Cuadra AE, et al. 2008. Perinatal loss of Nkx2-5 results in rapid conduction and contraction defects. Circ Res 103: 580-590.
11. Bruneau BG, Nemer G, Schmitt JP, et al. 2001. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 106: 709-721.
12. Cai CL, Zhou W, Yang L, et al. 2005. T-box genes coordinate regional rates of proliferation and regional specification during cardiogenesis. Development 132: 2475-2487.
13. Carniel E, Taylor MR, Sinagra G, et al. 2005. Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy. Circulation 112: 54-59.
14. Chambers JC, Zhao J, Terracciano CM, et al. 2010. Genetic variation in SCN10A influences cardiac conduction. Nat Genet 42: 149-152.
15. Cheng S, Keyes MJ, Larson MG, et al. 2009. Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA 301: 2571-2577.
16. Ching YH, Ghosh TK, Cross SJ, et al. 2005. Mutation in myosin heavy chain 6 causes atrial septal defect. Nat Genet 37: 423-428.
17. Cho YS, Go MJ, Kim YJ, et al. 2009. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet 41: 527-534.
18. Coppen SR, Kaba RA, Halliday D, et al. 2003. Comparison of connexin expression patterns in the developing mouse heart and human foetal heart. Mol Cell Biochem 242: 121-127.
19. Dekker JM, Crow RS, Hannan PJ, et al. 2004. Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middle-aged men and women: the ARIC study. J Am Coll Cardiol 43: 565-571.
20. Dekker JM, Schouten EG, Klootwijk P, et al. 1994. Association between QT interval and coronary heart disease in middle-aged and elderly men. The Zutphen Study. Circulation 90: 779-785.
21. Denny JC, Ritchie MD, Crawford DC, et al. 2010. Identification of genomic predictors of atrioventricular conduction: using electronic medical records as a tool for genome science. Circulation 122: 2016-2021
22. Desai AD, Yaw TS, Yamazaki T, et al. 2006. Prognostic significance of quantitative QRS duration. Am J Med 119: 600-606.
23. Dhingra R, Pencina MJ, Wang TJ, et al. 2006. Electrocardiographic QRS duration and the risk of congestive heart failure: the Framingham Heart Study. Hypertension 47: 861-867.
24. Dooley DC, Oppenlander BK, Xiao M. 2004. Analysis of primitive CD34- and CD34+ hematopoietic cells from adults: gain and loss of CD34 antigen by undifferentiated cells are closely linked to proliferative status in culture. Stem Cells 22: 556-569.
25. Eckel RH, Grundy SM, Zimmet PZ. 2005. The metabolic syndrome. Lancet 365: 1415-1428.
26. Elhendy A, Hammill SC, Mahoney DW, Pellikka PA. 2005. Relation of QRS duration on the surface 12-lead electrocardiogram with mortality in patients with known or suspected coronary artery disease. Am J Cardiol 96: 1082-1088.
27. Elkouby YM, Elias S, Casey ES, et al. 2010. Mesodermal Wnt signaling organizes the neural plate via Meis3. Development 137: 1531-1541.
28. Ellinor PT, Lunetta KL, Glazer NL, et al. 2010. Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet 42: 240-244.
29. Elming H, Holm E, Jun L, et al. 1998. The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J 19: 1391-1400.
30. Franco D, Lamers WH, Moorman AF. 1998. Patterns of expression in the developing myocardium: towards a morphologically integrated transcriptional model. Cardiovasc Res 38: 25-53.
31. Gudbjartsson DF, Arnar DO, Helgadottir A, et al. 2007. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 448: 353-357.
32. Gutstein DE, Morley GE, Tamaddon H, et al. 2001. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res 88: 333-339.
33. Hanson B, Tuna N, Bouchard T, et al. 1989. Genetic factors in the electrocardiogram and heart rate of twins reared apart and together. Am J Cardiol 63: 606-609.
34. Harris BS, Spruill L, Edmonson AM, et al. 2006. Differentiation of cardiac Purkinje fibers requires precise spatiotemporal regulation of Nkx2-5 expression. Dev Dyn 235: 38-49.
35. Hatcher CJ, Basson CT. 2009. Specification of the cardiac conduction system by transcription factors. Circ Res 105: 620-630.
36. Havlik RJ, Garrison RJ, Fabsitz R, et al. 1980. Variability of heart rate, P-R, QRS and Q-T durations in twins. J Electrocardiol 13: 45-48.
37. Hedley PL, Jøorgensen P, Schlamowitz S, et al. 2009. The genetic basis of long QT and short QT syndromes: a mutation update. Hum Mutat 30: 1486-1511.
38. Herron TJ, McDonald KS. 2002. Small amounts of alpha-myosin heavy chain isoform expression significantly increase power output of rat cardiac myocyte fragments. Circ Res 90: 1150-1152.
39. Holm H, Gudbjartsson DF, Arnar DO, et al. 2010. Several common variants modulate heart rate, PR interval and QRS duration. Nat Genet 42: 117-122.
40. James PF, Grupp IL, Grupp G, et al. 1999. Identification of a specific role for the na, K-ATPase alpha 2 isoform as a regulator of calcium in the heart. Mol Cell 3: 555-563.
41. Jay PY, Harris BS, Maguire CT, et al. 2004. Nkx2-5 mutation causes anatomic hypoplasia of the cardiac conduction system. J Clin Invest 113: 1130-1137.
42. Jouven X, Empana JP, Schwartz PJ, et al. 2005. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 352: 1951-1958.
43. Karjalainen J, Reunanen A, Ristola P, Viitasalo M. 1997. QT interval as a cardiac risk factor in a middle aged population. Heart 77: 543-548.
44. Katoh M, Katoh M. 2004. Identification and characterization of ARHGAP24 and ARHGAP25 genes in silico. Int J Mol Med 14: 333-338.
45. Kirk EP, Sunde M, Costa MW, et al. 2007. Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy. Am J Hum Genet 81: 280-291.
46. Klaus A, Birchmeier W. 2009. Developmental signaling in myocardial progenitor cells: a comprehensive view of Bmp- and Wnt/beta-catenin signaling. Pediatr Cardiol 30: 609-616.
47. Kurabayashi M, Tsuchimochi H, Komuro I, et al. 1988. Molecular cloning and characterization of human cardiac alpha- and beta-form myosin heavy chain complementary DNA clones. Regulation of expression during development and pressure overload in human atrium. J Clin Invest 82: 524-531.
48. Li J, Huo Y, Zhang Y, et al. 2009. Familial aggregation and heritability of electrocardiographic intervals and heart rate in a rural Chinese population. Ann Noninvasive Electrocardiol 14: 147-152.
49. Li QY, Newbury-Ecob RA, Terrett JA, et al. 1997. Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat Genet 15: 21-29.
50. Linden H, Williams R, King J, et al. 2009. Ulnar mammary syndrome and TBX3: expanding the phenotype. Am J Med Genet A 149A: 2809-2812.
51. Lompré AM, Nadal-Ginard B, Mahdavi V. 1984. Expression of the cardiac ventricular alpha- and beta-myosin heavy chain genes is developmentally and hormonally regulated. J Biol Chem 259: 6437-6446.
52. MacLennan DH, Kranias EG. 2003. Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 4: 566-577.
53. McFadden DG, Barbosa AC, Richardson JA, et al. 2005. The Hand1 and Hand2 transcription factors regulate expansion of the embryonic cardiac ventricles in a gene dosage-dependent manner. Development 132: 189-201.
54. Meysen S, Marger L, Hewett KW, et al. 2007. Nkx2.5 cell-autonomous gene function is required for the postnatal formation of the peripheral ventricular conduction system. Dev Biol 303: 740-753.
55. Moskowitz IP, Pizard A, Patel VV, et al. 2004. The T-Box transcription factor Tbx5 is required for the patterning and maturation of the murine cardiac conduction system. Development 131: 4107-4116.
56. Moskowitz IP, Kim JB, Moore ML, et al. 2007. A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development. Cell 129: 1365-1376.
57. Munshi NV, McAnally J, Bezprozvannaya S, et al. 2009. Cx30.2 enhancer analysis identifies Gata4 as a novel regulator of atrioventricular delay. Development 136: 2665-2674.
58. Mutikainen S, Ortega-Alonso A, Alén M, et al. 2009. Genetic influences on resting electrocardiographic variables in older women: a twin study. Ann Noninvasive Electrocardiol 14: 57-64.
59. Newton-Cheh C, Eijgelsheim M, Rice KM, et al. 2009. Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet 41: 399-406.
60. Newton-Cheh C, Guo CY, Wang TJ, et al. 2007. Genome-wide association study of electrocardiographic and heart rate variability traits: the Framingham Heart Study. BMC Med Genet 8 Suppl 1: S7.
61. Newton-Cheh C, Larson MG, Corey DC, et al. 2005. QT interval is a heritable quantitative trait with evidence of linkage to chromosome 3 in a genome-wide linkage analysis: The Framingham Heart Study. Heart Rhythm 2: 277-284.
62. Oikarinen L, Nieminen MS, Viitasalo M, et al. 2004. QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 43: 1029-1034.
63. Okin PM, Devereux RB, Howard BV, et al. 2000. Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study. Circulation 101: 61-66.
64. Palatini P, Julius S. 2004. Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens 26: 637-644.
65. Panáaková D, Werdich AA, Macrae CA. 2010. Wnt11 patterns a myocardial electrical gradient through regulation of the L-type Ca(2+) channel. Nature 466: 874-878.
66. Pandur P, Läasche M, Eisenberg LM, Kü M. 2002. Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature 418: 636-641.
67. Patel U, Pavri BB. 2009. Short QT syndrome: a review. Cardiol Rev 17: 300-303.
68. Pennisi DJ, Wilkinson L, Kolle G, et al. 2007. Crim1KST264/KST264 mice display a disruption of the Crim1 gene resulting in perinatal lethality with defects in multiple organ systems. Dev Dyn 236: 502-511.
69. Pfeufer A, Sanna S, Arking DE, et al. 2009. Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat Genet 41: 407-414.
70. Pfeufer A, van Noord C, Marciante KD, et al. 2010. Genome-wide association study of PR interval. Nat Genet 42: 153-159.
71. Rabert DK, Koch BD, Ilnicka M, et al. 1998. A tetrodotoxin-resistant voltage-gated sodium channel from human dorsal root ganglia, hPN3/SCN10A. Pain 78: 107-114.
72. Reamon-Buettner SM, Ciribilli Y, Inga A, Borlak J. 2008. A loss-of-function mutation in the binding domain of HAND1 predicts hypoplasia of the human hearts. Hum Mol Genet 17: 1397-1405.
73. Reamon-Buettner SM, Ciribilli Y, Traverso I, et al. 2009. A functional genetic study identifies HAND1 mutations in septation defects of the human heart. Hum Mol Genet 18: 3567-3578.
74. Ruan Y, Liu N, Priori SG. 2009. Sodium channel mutations and arrhythmias. Nat Rev Cardiol 6: 337-348.
75. Russell MW, Law I, Sholinsky P, Fabsitz RR. 1998. Heritability of ECG measurements in adult male twins. J Electrocardiol 30 Suppl: 64-68.
76. Schmitt JP, Kamisago M, Asahi M, et al. 2003. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299: 1410-1413.
77. Schott JJ, Benson DW, Basson CT, et al. 1998. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281: 108-111.
78. Schouten EG, Dekker JM, Meppelink P, et al. 1991. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 84: 1516-1523.
79. Schwartz PJ, Stramba-Badiale M, Crotti L, et al. 2009. Prevalence of the congenital long-QT syndrome. Circulation 120: 1761-1767.
80. Sharp DS, Masaki K, Burchfiel CM, et al. 1998. Prolonged QTc interval, impaired pulmonary function, and a very lean body mass jointly predict all-cause mortality in elderly men. Ann Epidemiol 8: 99-106.
81. Singh JP, Larson MG, O'Donnell CJ, et al. 1999. Heritability of heart rate variability: the Framingham Heart Study. Circulation 99: 2251-2254.
82. Sotoodehnia N, Isaacs A, de Bakker PI, et al. 2010. Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet 42: 1068-1076.
83. Stroud DM, Gaussin V, Burch JB, et al. 2007. Abnormal conduction and morphology in the atrioventricular node of mice with atrioventricular canal targeted deletion of Alk3/Bmpr1a receptor. Circulation 116: 2535-2543.
84. Takeda M, Briggs LE, Wakimoto H, et al. 2009. Slow progressive conduction and contraction defects in loss of Nkx2-5 mice after cardiomyocyte terminal differentiation. Lab Invest 89: 983-993.
85. van Wijk B, Moorman AF, van den Hoff MJ. 2007. Role of bone morphogenetic proteins in cardiac differentiation. Cardiovasc Res 74: 244-255.
86. Wilkinson L, Kolle G, Wen D, et al. 2003. CRIM1 regulates the rate of processing and delivery of bone morphogenetic proteins to the cell surface. J Biol Chem 278: 34181-34188.
87. Zhao YY, Liu Y, Stan RV, et al. 2002. Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc Natl Acad Sci U S A 99: 11375-11380.